Follow us on Twitter
twitter icon@FreshPatents

Cardiac Arrhythmia patents

Bulk PDF Downloads
      

This page is updated frequently with new Cardiac Arrhythmia-related patent applications.




 Novel methods for the treatment of cardiac arrhythmias patent thumbnailNovel methods for the treatment of cardiac arrhythmias
The present invention relates to the therapeutic modulation of cardiac caveolin-1 to mitigate cardiac arrhythmias.. .
United States Government As Represented By The Department Of Veterans Affairs


 Systems and methods for treating cardiac arrhythmias patent thumbnailSystems and methods for treating cardiac arrhythmias
Systems and methods for rate-adaptive pacing are disclosed. In one illustrative embodiment, a medical device for delivering electrical stimulation to a heart may include a housing configured to be implanted on the heart or within a chamber of the heart, one or more electrodes connected to the housing, and a controller disposed within the housing.
Cardiac Pacemakers, Inc.


 Sensing vector selection in a cardiac stimulus device with postural assessment patent thumbnailSensing vector selection in a cardiac stimulus device with postural assessment
Methods, implantable medical devices and systems configured to perform analysis of captured signals from implanted electrodes to identify cardiac arrhythmias. In an illustrative embodiment, signals captured from two or more sensing vectors are analyzed, where the signals are captured with a patient in at least first and second body positions.
Cameron Health Inc.


 Systems and methods for treating cardiac arrhythmias patent thumbnailSystems and methods for treating cardiac arrhythmias
Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an sicd comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device.
Cardiac Pacemakers, Inc.


 Systems and methods for treating cardiac arrhythmias patent thumbnailSystems and methods for treating cardiac arrhythmias
An implantable medical device (imd) may include a housing having a proximal end and a distal end and a set of one or more electrodes connected to but spaced apart from the housing. The imd may further include a controller disposed within the housing, wherein the controller is configured to sense cardiac electrical signals, and deliver electrical stimulation pulses via the first set of one or more electrodes.
Cardiac Pacemakers, Inc.


 Use of electrically conductive materials for electrophysiology patent thumbnailUse of electrically conductive materials for electrophysiology
Some embodiments of the present disclosure pertain to methods of improving electrical conduction across an impaired region of a tissue (e.g., myocardial tissue) by applying an electrically conductive material (e.g., carbon nanotube fibers) across the impaired region. The electrically conductive materials can become associated with non-impaired regions of the tissue on opposite sides of the impaired region by suturing.
Texas Heart Institute


 Method and  automatic arrhythmia classification with confidence estimation patent thumbnailMethod and automatic arrhythmia classification with confidence estimation
An arrhythmia classification system receives cardiac data from an implantable medical device, performs automatic adjudication of each cardiac arrhythmia episode indicated by the cardiac data, and generates episode data representative of information associated with the episode. The episode data include at least an episode classification resulting from the automatic adjudication of the episode and a confidence level in the episode classification.
Cardiac Pacemakers, Inc.


 Detection of reduced-control cardiac zones patent thumbnailDetection of reduced-control cardiac zones
A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity.
Tylerton International Inc.


 Defibrillator device patent thumbnailDefibrillator device
A defibrillator device is provided. The defibrillator device includes a first electrode, a second electrode, a readout module, a usb interface, a voltage converter and a stimulation module.
Winbond Electronics Corp.


 Methods of treating a cardiac arrhythmia by thoracoscopic production of a cox maze iii lesion set patent thumbnailMethods of treating a cardiac arrhythmia by thoracoscopic production of a cox maze iii lesion set
Methods of treating a subject for a cardiac arrhythmia are provided. Aspects of the methods include thoracoscopically producing a cardiac cox maze iii set of lesions in cardiac tissue of the subject in a manner sufficient to treat the subject for the cardiac arrhythmia..
Lc Therapeutics, Inc.


Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage


The invention provides various methods of identifying myocardial infarction (mi) patients who have microvascular obstruction (mo), persistent microvascular obstruction (pmo), reperfusion hemorrhage, iron deposition, chronic iron deposition, and/or fat infiltration/accumulation. The invention provides various methods of identifying myocardial infarction (mi) patients who are at risk of prolonged inflammation burden in heart, adverse cardiac remodeling, electrical abnormality, mechanical abnormality, malignant cardiac arrhythmia, ischemic heart failure, and/or sudden cardiac death.

Novel biphenyl derivative and preparing same


The present invention provides novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, methods for preparing the same, and a pharmaceutical composition containing the same. The novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, as disclosed in the present invention, act as muscarinic m3 receptor antagonists, and thus are useful for the prevention or treatment of a disease selected from the group consisting of chronic obstructive pulmonary disease, asthma, irritable bowel syndrome, urinary incontinence, rhinitis, spasmodic colitis, chronic cystitis, alzheimer's disease, senile dementia, glaucoma, schizophrenia, gastroesophageal reflux disease, cardiac arrhythmia, and hyper-salivation syndromes..

Systems and methods for managing tiered tachycardia therapy


Systems and methods are provided for managing tiered tachycardia therapy. The systems and methods measure a cardiac feature of interest (foi) from a cardiac electrical signal of a heart sensed from at least one electrode of a leadless cardiac pacemaker (lpm).

Timed energy delivery


A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects.
Medtronic Ablation Frontiers Llc


Medical premonitory event estimation


A system and method for medical premonitory event estimation includes one or more processors to perform operations comprising: acquiring a first set of physiological information of a subject, and a second set of physiological information of the subject received during a second period of time; calculating first and second risk scores associated with estimating a risk of a potential cardiac arrhythmia event for the subject based on applying the first and second sets of physiological information to one or more machine learning classifier models, providing at least the first and second risk scores associated with the potential cardiac arrhythmia event as a time changing series of risk scores, and classifying the first and second risk scores associated with estimating the risk of the potential cardiac arrhythmia event for the subject based on the one or more thresholds.. .
Zoll Medical Corporation


Techniques for predicting cardiac arrhythmias based on signals from leads of electrocardiography


Techniques for predicting cardiac arrhythmia includes obtaining first data that indicates an electrocardiography recording from a patient; and, automatically deriving, on a processor, p-wave characteristics on a plurality of leads of the electrocardiography recording. A value for a first parameter, pindex3, is determined based on a standard deviation of p-wave duraations automatically derived from only three leads of the plurality of leads.
The Board Of Trustees Of The Leland Stanford Junior University


System and decrement evoked potential (deep) mapping to identify components of the arrythmogenic circuit in cardiac arrhythmias


Various embodiments are described herein for a system and a method for identifying the arrhythmogenic circuit of a patient or subject. In one embodiment, the method comprises obtaining data for electrograms recorded at various locations of the heart while programmed ventricular pacing with extra stimuli was performed, obtaining decrement values for at least two different locations of the heart using the recorded electrograms, generating at least a portion of a decrement map using the decrement values, and identifying the arrhythmogenic circuit based on electrograms having significant decremental properties..
University Health Network


Methods and systems for generating integrated substrate maps for cardiac arrhythmias


An electrophysiology map, for example a map of arrhythmic substrate, can be generated by acquiring both geometry information and electrophysiology information pertaining to an anatomical region, and associating the acquired geometry and electrophysiology information as a plurality of electrophysiology data points. A user can select two (or more) electrophysiological characteristics for display, and can further elect to apply various filters to the selected electrophysiological characteristics.

Implantable cardio defibrillator (icd), subcutaneous implantable cardio defibrillator (sicd), and waveform energy control systems


Cardiac defibrillation or cardioversion waveform energy control systems employ transvenous icds or subcutaneous sicds for treating cardiac arrhythmias. The systems comprise differentially driven amplifier circuit operational modes to control the delivery of defibrillation or cardioversion electrical shocks, wherein the shock waveforms are constant current, constant voltage, or constant energy.

Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Methods of administering dantrolene for the acute treatment of cardiac arrhythmias


The present description relates to methods of administering effective amounts of an anti-arrhythmic agent, e.g., dantrolene, azumolene or a pharmaceutically acceptable salt thereof, for the acute treatment of cardiac arrhythmias, e.g., atrial fibrillation, premature ventricular contraction, ventricular tachycardia or ventricular fibrillation, and prevention of subsequent cardiac arrhythmias, wherein the methods effectuate a reduction in morbidity and mortality.. .

Wearable cardioverter defibrillator (wcd) system informing patient that it is validating just-detected cardiac arrhythmia


In some embodiments, a wearable cardioverter defibrillator (“wcd”) system may output an opening human-perceptible indication, after detecting a shockable cardiac arrhythmia but before validating it. This may succeed in informing the patient that the wcd system is working, and in particular analyzing a just-detected cardiac arrhythmia.
West Affum Holdings Corp.


Adaptive medium voltage therapy for cardiac arrhythmias


Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (mvt) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of mvt parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of mvt.
Galvani, Ltd.


Method of regulating cardiac arrhythmias


A method of treating cardiac arrhythmia. The method comprises oral ingestion of liquid comprising quinine, or the stereoisomer quinidine.

Energy delivery systems and uses thereof


The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy..
Neuwave Medical, Inc.


Short acting phenylalkylamine calcium channel blockers and uses thereof


The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow. The invention also relates to pharmaceutical compositions formulated for use in such methods and to kits for such methods..
Milestone Pharmaceuticals Inc.


Method of reducing the occurrence of arrhythmias via photobiomodulation and same


In response to local or systemic inflammation in a patient, photobiomodulation therapy is applied to a cardiac location to reduce the risk and/or occurrence of cardiac arrhythmia. Once inflammation is identified, photobiomodulation therapy can be applied in any suitable fashion (e.g., via a catheter- or transesophageal probe-mounted photoemitter, via an externally-applied photoemitter, or via photoemitter incorporated into an implantable medical device).
St. Jude Medical, Atrial Fibrillation Division, Inc.


Methods, systems and devices for treating cardiac arrhythmias


Provided is a method of treating cardiac arrhythmia in a patient. The method comprises selecting a patient suffering from a cardiac arrhythmia and creating a flow pathway between a first vascular location and a second vascular location.
Rox Medical, Inc.


Systems and methods for visualizing and analyzing cardiac arrhythmias using 2-d planar projection and partially unfolded surface mapping processes


A method for projecting a 3d surface geometry onto a planar projection comprises: obtaining a 3d geometry of a chamber surface using an algorithm that generates angles and distances between points on the chamber surface that represent mapping information; applying a cutting curve to at least two points on the chamber surface; and at least partially unfolding at least a portion of the chamber surface along the cutting curve to form a planar projection that optimally preserves the angles and distances between points on the chamber surface.. .
St. Jude Medical, Atrial Fibrillation Division, Inc.


Methods of treatment of cardiac arrhythmias using vanoxerine and modification of diet


Disclosed embodiments are related to methods of treatment of cardiac arrhythmias comprising administration of vanoxerine (gbr 12909) in connection with food of a predetermined fat content to modulate the plasma level concentrations of vanoxerine in a patient.. .
Chanrx Corporation


Methods of administration of single doses of vanoxerine to terminate acute episodes of cardiac arrhythmia


Compositions and methods of treating patients suffering from symptoms of recent onset atrial fibrillation or atrial flutter comprising administration of a single dose of about 200 to about 400 mg of vanoxerine to return said patient to normal sinus rhythm in less than about 24 hours.. .
Chanrx Corporation


Pharmaceutical compositions comprising vanoxerine and antianginal compounds, and methods of administration of the same for treating episodes of cardiac arrhythmia, maintaining normal sinus rhythm, preventing recurrence of cardiac arrhythmia, and treatment of chronic cardiac arrhythmia in mammals


Disclosed embodiments are related to pharmaceutical compositions comprising vanoxerine and an antianginal compound and methods of administration of vanoxerine and an antianginal composition to maintain steady state pharmacological concentration levels in a mammal.. .
Chanrx Corporation


Method and percutaneous epicardial ablation of cardiac ganglionated plexi without myocardial injury


A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly having a distal end arranged to be positioned by the catheter into the pericardium, with the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space. A connector operatively couples the delivery tip of the medium delivery assembly to the treatment source, and the delivery tip of the medium delivery assembly including a plurality of delivery points for delivering the treatment medium at a plurality of treatment areas within the pericardial space.
Mayo Foundation For Medical Education And Research


Vanoxerine for self-administration for terminating acute episodes of cardiac arrhythmia in mammals


Methods of administration of vanoxerine wherein a patient, previously and successfully treated for cardiac arrhythmia with vanoxerine is prescribed a further dose for self-administration of a further dose of vanoxerine for treatment of a subsequent occurrence of cardiac arrhythmia.. .
Laguna Pharmaceuticals, Inc.


Re-trafficking of herg reverses long qt syndrome 2 phenotype in human ips-derived cardiomyocytes


The present invention relates to generating hipsc-derived cardiomyocytes and embryoid bodies that recapitulate the disease phenotype of long qt syndrome and their use in developing pharmacological treatments thereof. The present invention also includes the use of a compound which inhibits the ubiquitin-proteasome pathway for the preparation of a medicament for the prophylaxis or treatment of a disease associated with prolonged ventricular repolarization (cardiac arrhythmia) caused by one or more mutations in the amino acid sequence of the herg potassium channel..
Singapore Health Services Pte Ltd


Systems and methods to optimize anti-tachycardial pacing (atp)


Apparatus, systems and methods are provided for prevention and/or remediation of cardiac arrhythmias, e.g. Optimizing anti-tachycardia pacing (atp) algorithms.
Cardioflow Technologies, Llc


Energy delivery systems and uses thereof


The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for delivering energy to difficult to access tissue regions (e.g.
Neuwave Medical, Inc.


Cardiac cryolipolysis for the treatment of cardiac arrhythmia


A system, device, and method for the treatment of cardiac arrhythmia by, specifically, cryolipolysis of non-myocardial tissue and cryoablation of myocardial tissue. A system for treating cardiac arrhythmia may include a first thermal treatment device configured for placement within a heart in contact with myocardial tissue, a second thermal treatment device configured for placement in contact with pericardial tissue, an ablation energy source in communication with the first thermal treatment device, and a cooling energy source in communication with the second thermal treatment device, the cooling energy source causing the second thermal treatment device to reach a temperature insufficient for myocardial ablation when the second thermal treatment device is activated.
Medtronic Cryocath Lp


Systems and methods for treating cardiac arrhythmias


Systems and methods for treating cardiac arrhythmias. One example medical device system for delivering electrical stimulation therapy to a heart of a patient may comprise a leadless cardiac pacemaker (lcp) implanted within a heart of a patient and configured to determine occurrences of cardiac arrhythmias, a medical device configured to determine occurrences of cardiac arrhythmias and to deliver defibrillation shock therapy to the patient, wherein the lcp and the medical device are spaced from one another and communicatively coupled, and wherein after the lcp determines an occurrence of a cardiac arrhythmia, the lcp is configured to modify the defibrillation shock therapy of the medical device..
Cardiac Pacemakers, Inc.


Energy delivery systems and uses thereof


The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy..
Neuwave Medical, Inc.


Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Flexible high-density mapping catheter tips and flexible ablation catheter tips with onboard high-density mapping electrodes


Flexible high-density mapping catheter tips (10a) and flexible ablation catheter tips with onboard high-density mapping electrodes (18) are disclosed. These tips can be used for diagnosing and treating cardiac arrhythmias.
St. Jude Medical, Cardiology Division, Inc.


Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries


A method for extinguishing a cardiac arrhythmia utilizes destructive interference of the passing of the reentry wave tip of an anatomical reentry through a depolarized region created by a relatively low voltage electric field in such a way as to effectively unpin the anatomical reentry. Preferably, the relatively low voltage electric field is defined by at least one unpinning shock(s) that are lower than an expected lower limit of vulnerability as established, for example, by a defibrillation threshold test.
Washington University


Systems and methods for treating cardiac arrhythmias


Systems and methods for coordinating treatment of abnormal heart activity using multiple implanted devices within a patient. In one example, a leadless cardiac pacemaker (lcp) may receive signals related to one or more physiological conditions of a patient, wherein the lcp may be configured to deliver atp therapy to a heart.
Cardiac Pacemakers, Inc.


Apparatus and identifying atrial arrhythmia by far-field sensing


In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient.
Cameron Health, Inc.


Method and treating cardiac arrhythmias using electromagnetic resynchronization


A method and an apparatus for the treatment of cardiac arrhythmias using a weak pulsed magnetic field. A transducer that emits electromagnetic radiation of a prescribed frequency and peak intensity is placed on the patient's chest and, as a result, the weak electromagnetic field can cause activation, reactivation, inhibition or remodeling of electrophysiological change in cardiac tissue in an irradiated heart.
Aerotel Ltd.


Systems and methods for detecting and monitoring arrhythmias using the ppg


Systems and methods for detecting and monitoring arrhythmias from a signal are provided. A signal processing system may transform a signal using a wavelet transformation and analyze changes in features of the transformed signal to detect pulse rhythm abnormalities.
Nellcor Puritan Bennett Ireland


Novel piperazine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals


Novel piperazine compounds are disclosed. Also disclosed are pharmaceutical compositions containing these compounds and therapeutic methods of treating cardiac arrhythmias in mammals, particularly humans, including terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm using these compounds..
Laguna Pharmaceuticals, Inc.


Sensing vector selection in a cardiac stimulus device with postural assessment


Methods, implantable medical devices and systems configured to perform analysis of captured signals from implanted electrodes to identify cardiac arrhythmias. In an illustrative embodiment, signals captured from two or more sensing vectors are analyzed, where the signals are captured with a patient in at least first and second body positions.
Cameron Health, Inc.


Method and device for treating cardiac arrhythmias


The present invention provides both methods and devices for termination of arrhythmias, such as ventricular or atrial tachyarrhythmias. The device and method involves application of alternating current (ac) for clinically significant durations at selected therapeutic frequencies through the cardiac tissue to a subject experiencing arrhythmia.
The Johns Hopkins University


Systems and methods for leadless pacing and shock therapy


Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (sicd) and a leadless pacing device (lpd) are described. For example, the sicd may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia.
Medtronic, Inc.


System and providing noninvasive ventilation


The invention is a system that comprises both an airway and ventilation device (av) and an automated external defibrillator (aed) device. The system is provided with means for assisting only minimally trained persons to operate it in emergency situations involving respiratory failure and/or cardiac arrhythmias.
Inovytec Medical Solutions Ltd.


Systems and methods for treating cardiac arrhythmias


Systems and methods for coordinating treatment of abnormal heart activity using multiple implanted devices. In one example, a method of operating a medical system may comprise determining, by a first one of a plurality of implantable medical devices, a presence of an arrhythmia, wherein the first one of a plurality of implantable medical devices uses a first discrimination method to determine the presence of an arrhythmia, determining, by a second one of the plurality of implantable medical devices, a presence of an arrhythmia, wherein the second one of a plurality of implantable medical devices uses a second discrimination method to determine the presence of an arrhythmia, and communicating, by the first one of the plurality of implantable medical devices to a second one of the plurality of implantable medical devices, a message that is indicative of a detected arrhythmia by the first one of a plurality of implantable medical devices..
Cardiac Pacemakers, Inc.


System and patient-specific image-based guidance of cardiac arrhythmia therapies


A method and system for image-based patient-specific guidance of cardiac arrhythmia therapies is disclosed. A patient-specific anatomical heart model is generated from medical image data of a patient.

Pharmaceutical compositions containing enantiomerically pure and/or racemic mixtures of chiral piperazine compounds and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions


Disclosed embodiments are related to compositions of a chiral piperazine compounds including compositions comprising enantiomerically pure or racemic mixtures of said piperazine compounds, and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof.. .

Pharmaceutical compositions containing piperazine compounds in combination with a p450 inhibitor and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions


Disclosed embodiments are related to compositions of a piperazine compound and a p450 inhibitor, including compositions of a piperazine compound and one or more p450 inhibitors, and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof.. .

Energy delivery systems and uses thereof


The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy..
Neuwave Medical, Inc.


Sensor-activated rhythm analysis: a heuristic system for predicting arrhythmias by time-correlated electrocardiographic and non-electrocardiographic testing


A method and apparatus for monitoring biosignals (e.g. Bioelectrical signals) is disclosed.

Method and device for treating cardiac arrhythmias


The present invention provides both methods and devices for termination of arrhythmias, such as ventricular or atrial tachyarrhythmias. The device and method involves application of alternating current (ac) for clinically significant durations at selected therapeutic frequencies through the cardiac tissue to a subject experiencing arrhythmia.
The Johns Hopkins University


Catheter for percutaneous transcatheter ablation of cardiac arrhythmias using bipolar radiofrequency


A catheter that distributes bipolar radiofrequency for use during the percutaneous ablation of cardiac arrhythmias. The catheter comprising a flexible sheath, a handle, a pull-wire, holes for irrigation in its distal tip, sensing means and electrodes..

Screening procedure for identifying risk of arrhythmia


A screening procedure and apparatus enables those at risk of cardiac arrhythmia to be identified. The procedure utilises a blood flow detector (12) in conjunction with a signal analysis unit (18) to monitor a sequence of multiple heart pulses, hence to deduce the values of a sequence of multiple heart pulse intervals, and to analyse the sequence of multiple heart pulse intervals to deduce a risk parameter whose value enables those at risk of cardiac arrhythmia to be identified.
To Health Limited


Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Methods and compositions for correlating genetic markers with sudden cardiac death risk


The present invention provides a method of identifying a subject as having an increased risk of sudden cardiac death or cardiac arrhythmia by detecting in the subject the presence of various polymorphisms associated with an increased risk of sudden cardiac death or cardiac arrhythmia.. .
Duke University


Separating clinically relevant sources of electrical activity in ecg signals


This invention provides a fully automatic method and a system for detecting and classifying cardiac arrhythmias from a surface ecg record. The method defines four relevant parameters whose values are extracted from said ecg record.
Ben-gurion University Of The Negev Research & Development Authority




Cardiac Arrhythmia topics:
  • Arrhythmia
  • Cardiac Arrhythmia
  • Arrhythmias
  • Cardiac Arrhythmias
  • Fibrillation
  • Medical Device
  • Implantable Medical Device
  • Epinephrine
  • Ventricular
  • Tachycardia
  • Atrial Fibrillation
  • Atrial Fib
  • Electrical Signal
  • Sleep Apnea
  • Rheumatoid Arthritis


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Cardiac Arrhythmia for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cardiac Arrhythmia with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.717

    5491

    2 - 1 - 101